When [125I]calcitonin was injected intravenously into rats the major site of accumulation of radioactivity was the liver, whereas [125I]parathyroid hormone was localized chiefly in the kidney.
The distribution of [125I]bovine serum albumin and of Na [125I] was studied for comparison. Although most of the radioactivity of [125I]calcitonin was found in the soluble fractions of liver and kidney, significant binding to liver microsomes occurred. This fraction also bound an appreciable amount of the radioactivity of [125I]parathyroid hormone. The uptake of [125I]calcitonin by liver could be inhibited by the simultaneous injection of unlabelled calcitonin, but not by that of parathyroid hormone, insulin or adrenocorticotrophic hormone.
These results indicate a role for the liver and kidney in the early clearance of calcitonin and parathyroid hormone respectively. It is likely that the liver is the major site of the metabolism of calcitonin in vivo.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 4 | 3 | 0 |
| PDF Downloads | 2 | 0 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
